Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective Trial

To report early toxicity and tumor control outcomes of Pd-103 brachytherapy with ultrahypofractionated stereotactic radiation therapy (RT) for intermediate-risk prostate cancer.

Source: International Journal of Radiation Oncology * Biology * Physics - June 3, 2020 Category: Radiology Authors: Marisa A. Kollmeier, Sean McBride, Melissa Varghese, Dylan Debonis, Zhigang Zhang, Gilad Cohen, Antonio L. Damato, Borys Mychalczak, Richard Gewanter, Michael J. Zelefsky Tags: Clinical Investigation Source Type: research